Ipamorelin tablets are a type of pharmaceutical preparation containing Ipamorelin ingredients, which exist in tablet form. Ipamorelin is a growth hormone releasing peptide mimetic compound with a CAS number of 170851-70-4 and a molecular formula of C38H49N9O5. In terms of pharmacological effects, it stimulates the release of growth hormone (GH) from the anterior pituitary gland by activating the growth hormone releasing peptide receptor. Compared with some other growth hormone releasing peptides, it does not cause negative effects such as increased appetite, prolactin, cortisol, etc., while ensuring the benefits of growth hormone release. This selective mechanism of action makes it more precise and safe in regulating growth hormone levels.
In clinical applications, it exhibits various potential values. In the fields of sports medicine and bodybuilding, it can increase fat burning speed, maintain lean muscle tissue, help athletes and bodybuilders increase muscle mass, reduce fat accumulation, and improve athletic performance and body shape. In the field of anti-aging, it can improve age-related symptoms such as muscle atrophy, fat accumulation, and skin laxity, promote the recovery and strengthening of joints, connective tissue, and bone mass, and may also improve skin and hair quality. In addition, there are potential applications in the treatment of some diseases, such as in cancer cachexia patients, which may improve weight loss and loss of appetite, and enhance the quality of life of patients.
Our product
Additional information of chemical compound:
| Product Name | Ipamorelin Tablets | Ipamorelin Powder | Ipamorelin Injection |
| Product Type | Tablets | Powder | Injection |
| Product Purity | HPLC≥99.0% | ≥99% | ≥99% |
| Product Specifications | Customizable | Customizable | Customizable |
| Product Package | Customizable | Customizable | Customizable |
Our Product
Ipamorelin+. COA
 |
||
Certificate of Analysis |
||
|
Compound name |
Ipamorelin | |
|
CAS No. |
170851-70-4 | |
|
Grade |
Pharmaceutical grade | |
|
Quantity |
Customized | |
|
Packaging standard |
Customized | |
| Manufacturer | Shaanxi BLOOM TECH Co., Ltd | |
|
Lot No. |
20250109001 |
|
|
MFG |
Jan 12th 2025 |
|
|
EXP |
Jan 8th 2029 |
|
|
Structure |
|
|
| TEST STANDARD | GB/T24768-2009 Industry. Stnndard | |
|
Item |
Enterprise standard |
Analysis result |
|
Appearance |
White or almost white powder |
Conformed |
|
Water content |
≤4.5% |
0.30% |
| Loss on drying |
≤1.0% |
0.15% |
|
Heavy Metals |
Pb≤0.5ppm |
N.D. |
|
As≤0.5ppm |
N.D. | |
|
Hg≤0.5ppm |
N.D. | |
|
Cd≤0.5ppm |
N.D. | |
|
Purity (HPLC) |
≥99.0% |
99.5% |
|
Single impurity |
<0.8% |
0.48% |
|
Residue on ignition |
<0.20% |
0.064% |
|
Total microbial count |
≤750cfu/g |
80 |
|
E. Coli |
≤2MPN/g |
N.D. |
|
Salmonella |
N.D. | N.D. |
|
Ethanol (by GC) |
≤5000ppm |
400ppm |
|
Storage |
Store in a sealed, dark and dry place at-20 degrees |
|
|
||
Ipamorelin tablets mainly stimulates the release of growth hormone (GH) from the anterior pituitary gland by activating the growth hormone releasing peptide receptor. Compared with other growth hormone releasing peptides such as GHRP, Ipamorelin has unique advantages. It does not produce negative effects such as increased appetite, elevated prolactin, and elevated cortisol, while ensuring the benefits of growth hormone release. This selective mechanism of action makes Ipamorelin more precise and safe in regulating growth hormone levels. The process of activating the growth hormone releasing peptide receptor involves a series of complex intracellular signaling pathways that can sense the binding signal of Ipamorelin and transmit it to the nucleus, thereby regulating the expression of growth hormone genes and promoting the synthesis and release of growth hormone. In this way, Ipamorelin can effectively increase the level of growth hormone in the body without interfering with other hormone systems.
Interaction with growth hormone receptors
After binding to growth hormone receptors, Ipamorelin triggers a series of intracellular signal transduction processes. These signal transduction pathways can regulate functions such as cell growth, metabolism, and differentiation. For example, in muscle tissue, the signaling pathway activated by Ipamorelin can promote the synthesis of muscle proteins and increase muscle mass. It activates specific signaling molecules such as protein kinase B (Akt) and mammalian rapamycin target protein (mTOR), which can further regulate gene expression, promote protein synthesis in muscle cells, and promote muscle fiber growth. In adipose tissue, it can accelerate the breakdown and metabolism of fat, and increase the speed of fat burning. The signaling pathway activated by Ipamorelin can regulate the activity of lipolytic enzymes in adipocytes, promote fat breakdown, and inhibit fat synthesis, thereby reducing fat accumulation. This regulatory effect on cellular function makes Ipamorelin potentially valuable in improving body composition, enhancing exercise ability, and anti-aging.
Basic information
Composition and Chemical Structure
Ipamorelin tablets is a novel and effective growth hormone releasing peptide mimetic compound, with the chemical name Aib-His-D-2-Nal-D-Phe-Lys-NH ₂ and CAS number 170851-70-4. This specific chemical structure determines the unique biological activity and pharmacological effects of Ipamorelin. Compared with other growth hormone releasing peptides, Ipamorelin has been carefully designed structurally to act more accurately on growth hormone releasing peptide receptors, thereby exerting more efficient and safer effects. The amino acid sequence and modifications in its chemical structure enable it to selectively stimulate the release of growth hormone, while avoiding some adverse reactions that traditional drugs may cause.
Pharmacokinetic properties
After oral administration of Ipamorelin, its absorption, distribution, metabolism, and excretion processes in the body exhibit certain characteristics. In terms of absorption, the speed and degree of Ipamorelin absorption in the body are influenced by various factors, such as administration mode, dosage, and individual differences. Generally speaking, the absorption efficiency after oral administration may be affected by the gastrointestinal environment, and different physiological states of the gastrointestinal tract may lead to differences in absorption rate and degree. It has a wide distribution range and can reach different tissues and organs in the body, but mainly concentrated in areas related to growth hormone regulation, such as the anterior pituitary gland. During the metabolic process, Ipamorelin is mainly metabolized through the liver, where the enzyme system breaks it down and converts it into metabolites. These metabolites may have certain biological activity or no activity, and their subsequent fate and effects need further research. The main route of excretion is through the kidneys, in the form of urine. Understanding these pharmacokinetic characteristics can help us better grasp the dynamic changes of Ipamorelin in vivo and provide a basis for rational drug use.
Application in the fields of sports medicine and bodybuilding
Ipamorelin has received widespread attention from athletes and bodybuilders in the fields of sports medicine and bodybuilding. Its role in increasing fat burning rate and maintaining lean muscle tissue is of great significance for athletes and bodybuilders. By using Ipamorelin, athletes can increase muscle mass and strength, and improve athletic performance without adding too much fat. During the training process, muscle synthesis and breakdown are in a dynamic equilibrium state. Ipamorelin can promote muscle protein synthesis and inhibit muscle protein breakdown by regulating growth hormone levels, thereby increasing muscle mass.
At the same time, it can accelerate the metabolism of fat, improve the energy utilization efficiency of the body, enable athletes to better utilize fat as an energy source during exercise, reduce dependence on glycogen, and delay the occurrence of fatigue. In addition, Ipamorelin can accelerate recovery after exercise, reduce muscle damage and fatigue, and enable athletes to recover to their optimal state faster. After exercise, the body produces a series of inflammatory and oxidative stress reactions, leading to muscle damage and fatigue. Ipamorelin can promote muscle repair and regeneration, alleviate inflammatory and oxidative stress reactions, and accelerate post exercise recovery by regulating growth hormone levels. However, it should be noted that the use of Ipamorelin in sports competitions may pose a risk of violation and strict compliance with relevant laws, regulations, and competition rules is required.
Application in anti-aging field
As age increases, the level of growth hormone in the human body gradually decreases, which can lead to a series of aging related symptoms such as muscle atrophy, fat accumulation, skin laxity, joint pain, etc. Ipamorelin can improve these aging symptoms by regulating growth hormone levels. It can promote the recovery and strengthening of joints, connective tissue, and bone mass, improving the body's mobility and flexibility. Growth hormone plays an important role in bone growth and repair processes. Ipamorelin can stimulate the proliferation and differentiation of bone cells, promote the synthesis of bone matrix, thereby increasing bone mass and preventing the occurrence of osteoporosis.
At the same time, it can promote the repair and regeneration of joint cartilage, reduce joint pain and inflammation, and improve joint mobility. In terms of skin, Ipamorelin can improve skin quality and hair quality, making the skin firmer and more elastic, and making hair thicker and healthier. Growth hormone can promote the synthesis of collagen, increase skin thickness and elasticity, and reduce the formation of wrinkles. In addition, Ipamorelin may also have a positive impact on the body's metabolic function, regulating indicators such as blood sugar and blood lipids, and improving the overall health level of the body. Therefore, Ipamorelin has broad application prospects in the field of anti-aging and is expected to become an effective anti-aging drug.
Potential applications in the treatment of other diseases
In addition to the fields of sports medicine, bodybuilding, and anti-aging, Ipamorelin has also shown potential in the treatment of other diseases. For example, in cancer cachexia patients, Ipamorelin tablets may improve their quality of life by improving weight loss and loss of appetite. Cancer cachexia is a serious complication that can cause extreme physical weakness in patients, affecting treatment effectiveness and prognosis. Ipamorelin, as a ghrelin receptor agonist, can simulate the secretion of ghrelin from the gastrointestinal tract, increasing patients' appetite and weight. Gastric ghrelin plays an important role in regulating appetite and energy metabolism.
Ipamorelin activates gastric ghrelin receptors, which can promote gastrointestinal peristalsis and secretion of digestive fluids, increasing patients' appetite. At the same time, it can promote protein synthesis and fat storage, increase patients' weight, and enhance their physical resistance. In addition, Ipamorelin may also have a certain therapeutic effect on some diseases related to growth hormone deficiency, such as growth hormone deficiency, dwarfism, etc. Growth hormone plays a crucial role in the growth and development process of children. Ipamorelin can stimulate the release of growth hormone, promote children's growth and development, and improve patients' height and body proportions. But more clinical studies are still needed to confirm its efficacy and safety.
Ipamorelin represents a promising yet controversial tool in the arsenal of growth hormone modulation. Its selectivity and mild side effect profile make it attractive for research and niche medical applications, but the lack of robust clinical data and regulatory clarity limits its widespread adoption. As science advances, Ipamorelin may find its place in personalized anti-aging regimens or regenerative medicine, provided ethical and safety concerns are addressed. For now, patients and practitioners must navigate a landscape of uncertainty, weighing potential benefits against unproven risks and legal ambiguities. The future of Ipamorelin hinges on rigorous research, transparent regulation, and a nuanced understanding of its role in human health.
Frequently Asked Questions
Do peptides work in pill form?
+
-
Yes, some peptides work in pill form, but it's challenging due to stomach acids and enzymes breaking them down; however, new technologies like chemical modifications (e.g., cyclic peptides), nanoparticles, and specific absorption enhancers (like SNAC in Ozempic's oral version, Rybelsus) are making oral delivery possible for certain therapeutic peptides, like semaglutide (Wegovy/Ozempic), transforming them from injections to convenient tablets, though many supplements lack strong evidence.
What is CJC-1295 Ipamorelin in pill form?
+
-
CJC-1295 and Ipamorelin are peptides typically supplied as a powder for injection, requiring reconstitution, but you can find them in oral capsule/pill form, often sold as "natural" HGH support supplements or in blends for performance/anti-aging, though their effectiveness in pill form (oral bioavailability) is often debated vs. injection, with some vendors offering blends in capsules for convenience, while others focus on research-grade injectables.
What's the best peptide to lose belly fat?
+
-
Tesamorelin is used primarily for reducing abdominal fat. It stimulates the release of growth hormone, leading to an increase in muscle mass and a significant reduction in visceral fat. This makes Tesamorelin particularly beneficial for individuals struggling with stubborn belly fat.
What is the strongest peptide for muscle growth?
+
-
Sermorelin, Ipamorelin, and CJC1295 are often used to maximize muscle growth benefits. This trio is considered as effective as HGH injections, making it one of the best muscle growth peptides.
Hot Tags: ipamorelin tablets, suppliers, manufacturers, factory, wholesale, buy, price, bulk, for sale, 8H Dibenzo b b cyclopenta 2 1 e 4 3 g bisbenzofuran 6 10 diamine N6 N6 N10 N10 tetrakis 4 1 1 dimethylethyl phenyl 8 8 diphenyl , benzocaine 200mesh, 9 3 4 4 5 5 tetramethyl 1 3 2 dioxaborolan 2 yl phenyl 9H carbazole 3 carbonitrile, 6 4 bromopyridin 2 yl phenanthridine, 1 7 chlorodibenzo b d furan 1 yl 4 6 diphenyl 1 3 5 triazine, CAS 1807358 48 0